JP2024540161A5 - - Google Patents
Info
- Publication number
- JP2024540161A5 JP2024540161A5 JP2024525583A JP2024525583A JP2024540161A5 JP 2024540161 A5 JP2024540161 A5 JP 2024540161A5 JP 2024525583 A JP2024525583 A JP 2024525583A JP 2024525583 A JP2024525583 A JP 2024525583A JP 2024540161 A5 JP2024540161 A5 JP 2024540161A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273290P | 2021-10-29 | 2021-10-29 | |
| US63/273,290 | 2021-10-29 | ||
| PCT/US2022/078836 WO2023077041A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 modulators for the treatment of heart failure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540161A JP2024540161A (ja) | 2024-10-31 |
| JPWO2023077041A5 JPWO2023077041A5 (https=) | 2025-10-31 |
| JP2024540161A5 true JP2024540161A5 (https=) | 2025-10-31 |
Family
ID=84362101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525583A Pending JP2024540161A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240417369A1 (https=) |
| EP (1) | EP4423094B1 (https=) |
| JP (1) | JP2024540161A (https=) |
| KR (1) | KR20240095290A (https=) |
| CN (1) | CN118176197A (https=) |
| ES (1) | ES3058993T3 (https=) |
| WO (1) | WO2023077041A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121605099A (zh) * | 2023-08-10 | 2026-03-03 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2803920A1 (en) | 2010-06-24 | 2011-12-29 | Richard Beard | Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| WO2013165606A1 (en) * | 2012-05-04 | 2013-11-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| AR124193A1 (es) * | 2020-12-08 | 2023-02-22 | Astrazeneca Ab | Compuestos moduladores de rxfp1 |
-
2022
- 2022-10-28 KR KR1020247017526A patent/KR20240095290A/ko active Pending
- 2022-10-28 US US18/700,868 patent/US20240417369A1/en active Pending
- 2022-10-28 JP JP2024525583A patent/JP2024540161A/ja active Pending
- 2022-10-28 CN CN202280072729.2A patent/CN118176197A/zh active Pending
- 2022-10-28 WO PCT/US2022/078836 patent/WO2023077041A1/en not_active Ceased
- 2022-10-28 EP EP22813058.9A patent/EP4423094B1/en active Active
- 2022-10-28 ES ES22813058T patent/ES3058993T3/es active Active